Share this article
LAS VEGAS, April 14, 2021 /PRNewswire/ DelveInsight s
Parkinson s Disease Market report provides a thorough comprehension of the Parkinson s Disease, historical and forecasted epidemiology, and the Parkinson s Disease market trends in the 7MM [the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan]. The Parkinson s Disease market report also proffers an analysis of the current Parkinson s Disease treatment algorithm/practice, market drivers, market barriers, and unmet medical needs.
Key takeaways of the
The increase in Parkinson s disease prevalent population in the 7MM and the expected entry of premium price assets will influence market size growth.
Share this article
LAS VEGAS, April 13, 2021 /PRNewswire/ DelveInsight s
Ascites Market report provides a thorough comprehension of the Ascites, historical and forecasted epidemiology, and the Ascites market trends in the 7MM [the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan]. The Ascites market report also proffers an analysis of the current Ascites treatment algorithm/practice, market drivers, market barriers, and unmet medical needs.
Some of the key takeaways of the
Tolvaptan, a novel aquaporin modulator, was made available in Japan in 2013 to treat patients with refractory Ascites due to cirrhosis. However, it is not approved in Japan for the Ascites treatment.
Share this article
LAS VEGAS, April 12, 2021 /PRNewswire/ The
Cancer Anorexia report provides a detailed view of the Cancer Anorexia market forecasts up to 2030, analysis of treatment landscape, promising emerging therapies, changing market landscape, individual market share of pipeline therapies, Cancer Anorexia market drivers, and market barriers, Cancer Anorexia market size during the study period 2018-30 in the 7MM.
The
Cancer Anorexia Market report is created to uncover authentic opportunities in the Cancer Anorexia market landscape in the 7MM (the US, EU5 (the UK, Germany, Italy, Spain, and France), and Japan), help clients form collaborations and ink deals that give them a competitive advantage and plan strategic moves to yield maximum returns.
Share this article
LAS VEGAS, April 8, 2021 /PRNewswire/ DelveInsight s
Epidermal Growth Factor Receptor (EGFR) Inhibitors-Induced Skin Disorders Market report provides a thorough comprehension of the EGFR Inhibitors-Induced Skin Disorders, historical and forecasted epidemiology, and the Epidermal Growth Factor Receptor Inhibitors-Induced Skin Disorders market trends in the 7MM [the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan]. The EGFR Inhibitors-Induced Skin Disorders market report also proffers an analysis of the current EGFR Inhibitors-Induced Skin Disorders treatment algorithm/practice, market drivers, market barriers, and unmet medical needs.
Some of the key takeaways of the
There is no approved therapy specific for anti-EGFR induced skin diseases in the US, EU, and Japan.
Share this article
LAS VEGAS, April 7, 2021 /PRNewswire/ DelveInsight s
Cluster Headache Market report provides a thorough comprehension of the Cluster Headache, historical and forecasted epidemiology, and the Cluster Headache market trends in the 7MM [the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan]. The Cluster Headache market report also proffers an analysis of the current Cluster Headache treatment algorithm/practice, market drivers, market barriers, and unmet medical needs.
Some of the key takea
ways of the
Many patients are undertreated, and in some cases, not treated. Cluster Headache patients are more likely to use prescription and nonprescription pain medications, including opiates.